Longitudinal assessment of monocyte chemoattractant protein-1 in lupus nephritis as a biomarker of disease activity

Clinical Rheumatology

Volumn 35, Issue 11, 2016, Pages 2707-2714

  Gupta, Ranjan ^a   Yadav, Akhilesh ^a   Aggarwal, Amita ^a  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Glomerulonephritis; Kidney disease; Proteomic; SLE; Urinary

Indexed keywords

AZATHIOPRINE; CALCIUM; CYCLOPHOSPHAMIDE; HYDROXYCHLOROQUINE; MONOCYTE CHEMOTACTIC PROTEIN 1; MYCOPHENOLIC ACID; RITUXIMAB; STEROID; VITAMIN D; BIOLOGICAL MARKER; CREATININE;

ADULT; ARTICLE; BLOOD SAMPLING; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DISEASE ACTIVITY; DRUG MEGADOSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; HEMATURIA; HUMAN; HUMAN TISSUE; KIDNEY BIOPSY; LOW DRUG DOSE; LUPUS ERYTHEMATOSUS NEPHRITIS; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; MEMBRANOUS GLOMERULONEPHRITIS; NONPARAMETRIC TEST; PRIORITY JOURNAL; PROSPECTIVE STUDY; PYURIA; RELAPSE; RHEUMATOID ARTHRITIS; SLEDAI; URINE SAMPLING; VITAMIN SUPPLEMENTATION; ADOLESCENT; BLOOD; CHILD; LUPUS NEPHRITIS; METABOLISM; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; URINE; YOUNG ADULT;

ADOLESCENT; ADULT; ARTHRITIS, RHEUMATOID; BIOMARKERS; CHEMOKINE CCL2; CHILD; CREATININE; DIABETIC NEPHROPATHIES; FEMALE; HUMANS; LUPUS NEPHRITIS; MALE; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 84987667565     PISSN: 07703198     EISSN: 14349949     Source Type: Journal    
DOI: 10.1007/s10067-016-3404-9     Document Type: Article

References (28)

1. Ward MM (2009) Changes in the incidence of end-stage renal disease due to lupus nephritis in the United States, 1996–2004. J Rheumatol 36:63–67
2. Misra R, Gupta R (2015) Biomarkers in lupus nephritis. Int J Rheum Dis 18:219–232
3. Hasegawa H, Kohno M, Sasaki M, et al. (2003) Antagonist of monocyte chemoattractant protein ameliorates the initiation and progression of lupus nephritis and renal vasculitis in MRL/lpr mice. Arthritis Rheum 48:2555–2566
4. Clark MR, Trotter K, Chang A (2015) The pathogenesis and therapeutic implications of tubulointerstitial inflammation in human lupus nephritis. Semin Nephrol 35(5):455–464
5. Gupta R, Yadav A, Misra R, Aggarwal A (2015) Urinary sCD25 as a biomarker of lupus nephritis disease activity. Lupus 24:273–279
6. Abujam B, Cheekatla S, Aggarwal A (2013) Urinary CXCL-10/IP-10 and MCP-1 as markers to assess activity of lupus nephritis. Lupus 22(6):614–623
7. Torabinejad S, Mardani R, Habibagahi Z, et al. (2012) Urinary monocyte chemotactic protein-1 and transforming growth factor-β in systemic lupus erythematosus. Indian J Nephrol 22(1):5–12
8. Susianti H, Iriane VM, Dharmanata S, et al. (2015) Analysis of urinary TGF-β1, MCP-1, NGAL, and IL-17 as biomarkers for lupus nephritis. Pathophysiology 22(1):65–71
9. Alharazy S, Kong NCT, Mohd M, et al. (2014) Urinary monocyte chemoattractant protein and lupus nephritis activity. J Clin Cell Immunol 5:187. doi:10.4172/2155-9899.1000187
10. Alharazy S, Kong NC, Mohd M, Shah SA, Ba'in A, Abdul Gafor AH (2015) Urine monocyte chemoattractant protein-1 and lupus nephritis disease activity: preliminary report of a prospective longitudinal study. Autoimmune Dis 2015:962046
11. Ghobrial EE, El Hamshary AA, Mohamed AG, Abd El Raheim YA, Talaat AA (2015) Urinary monocyte chemoattractant protein-1 as a biomarker of lupus nephritis activity in children. Saudi J Kidney Dis Transpl 26(3):507–515
12. Barbado J, Martin D, Vega L, et al. (2012) MCP-1 in urine as biomarker of disease activity in systemic lupus erythematosus. Cytokine 60(2):583–586
13. Mirfeizi Z, Mahmoudi M, Naghibi M, et al. (2012) Urine monocyte chemoattractant protein-1(UMCP-1) as a biomarker of renal involvement in systemic lupus erythematosus. Iran J Basic Med Sci 15(6):1191–1195
14. Rosa RF, Takei K, Araújo NC, Loduca SM, Szajubok JC, Chahade WH (2012) Monocyte chemoattractant-1 as a urinary biomarker for the diagnosis of activity of lupus nephritis in Brazilian patients. J Rheumatol 39(10):1948–1954
15. Marks SD, Shah V, Pilkington C, Tullus K (2010) Urinary monocyte chemoattractant protein-1 correlates with disease activity in lupus nephritis. Pediatr Nephrol 25(11):2283–2288
16. Alzawawy A, Zohary M, Ablordiny M, Eldalie M (2009) Estimation of monocyte-chemoattractantprotein-1 (Mcp-1) level in patients with lupus nephritis. Int J Rheum Dis 12(4):311–318
17. Kiani AN, Johnson K, Chen C, et al. (2009) Urine osteoprotegerin and monocyte chemoattractant protein-1 in lupus nephritis. J Rheumatol 36:2224–2230
18. Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40:1725
19. Hahn BH, McMahon MA, Wilkinson A, et al. (2012) American College of Rheumatology guidelines for screening, treatment, and management of lupus nephritis. Arthritis Care Res (Hoboken) 64:797–808
20. Tesch GH, Maifert S, Schwarting A, Rollins BJ, Kelley VR (1999) Monocyte chemoattractant protein 1-dependent leukocytic infiltrates are responsible for autoimmune disease in MRL-Fas(lpr) mice. J Exp Med 190(12):1813–1824
21. Tesch GH (2008) MCP-1/CCL2: a new diagnostic marker and therapeutic target for progressive renal injury in diabetic nephropathy. Am J Physiol Renal Physiol 294(4):F697–F701
22. Shoukry A, Bdeer S-A, El-Sokkary RH (2015) Urinary monocyte chemoattractant protein-1 and vitamin D-binding protein as biomarkers for early detection of diabetic nephropathy in type 2 diabetes mellitus. Mol Cell Biochem 408(1–2):25–35
23. Tucci M, Barnes EV, Sobel ES, et al. (2004) Strong association of a functional polymorphism in the monocyte chemoattractant protein 1 promoter gene with lupus nephritis. Arthritis Rheum 50(6):1842–1849
24. Nasri H, Ahmadi A, Baradaran A, et al. (2014) Clinicopathological correlations in lupus nephritis; a single center experience. J Nephropathol 3:115–120
25. Rovin BH, Song H, Birmingham DJ, Hebert LA, Yu CY, Nagaraja HN (2005) Urine chemokines as biomarkers of human systemic lupus erythematosus activity. J Am Soc Nephrol 16(2):467–473
26. Gharaee-Kermani M, Denholm EM, Phan SH (1996) Costimulation of fibroblast collagen and transforming growth factor B1 gene expression by monocyte chemoattractant protein-1 via specific receptors. J Biol Chem 271:17779–17784
27. Lloyd CM, Minto AW, Dorf ME, et al. (1997) RANTES and monocyte chemoattractant protein-1 play an important role in the inflammatory phase of crescentic nephritis but only MCP-1 is involved in crescent formation and interstitial fibrosis. J Exp Med 185:1371–1380
28. Singh RG, Usha, Rathore SS, Behura SK, Singh NK (2012) Urinary MCP-1 as diagnostic and prognostic marker in patients with lupus nephritis flare. Lupus 21(11):1214–1218